[Research progress of tolvaptan in the treatment of refractory ascites in cirrhosis]. [PDF]
Zhang QQ, Chen Y, Chen YX, Yang L.
europepmc +1 more source
[New targets for the prevention and treatment of cirrhotic portal vein thrombosis]. [PDF]
Wang YW, Ding HG.
europepmc +1 more source
[A case of Castleman's disease misdiagnosed as cirrhosis]. [PDF]
Gao YF +6 more
europepmc +1 more source
[Tenofovir amibufenamide treatment in a case of hepatitis B virus-related decompensated liver cirrhosis]. [PDF]
Li YP, Gou GE, Dang SS.
europepmc +1 more source
[Pay attention to the diagnosis and treatment of "easily neglected" complications in liver cirrhosis]. [PDF]
Xu JH, Yu YY, Xu XY.
europepmc +1 more source
[Real-world study of tenofovir amibufenamide in the treatment of patients with hepatitis B cirrhosis]. [PDF]
Han Y +5 more
europepmc +1 more source
[Tenofovir amibufenamide inhibiting low-level viremia and delaying the progression of liver cirrhosis: a case report]. [PDF]
Zhao CY, Nie CF, Zhao ZH.
europepmc +1 more source
[Meta-analysis of the efficacy of the Fuzheng Huayu formula in the treatment of hepatitis B-associated liver fibrosis or cirrhosis]. [PDF]
Fan Y +5 more
europepmc +1 more source
[A case of hepatitis B cirrhosis combined with streptococcal spondylitis and secondary pan-drug-resistant bacterial infection]. [PDF]
Ren J, Xu J.
europepmc +1 more source
[Study on the efficacy and safety profile of tenofovir alafenamide fumarate in the treatment of patients with decompensated hepatitis B cirrhosis]. [PDF]
Guo F +14 more
europepmc +1 more source

